Tag: Breaking

Strong Travel Demand Fuels Financial Growth and Shareholder Payouts Royal Caribbean Cruises (RCL) has become the first major cruise operator ...

Obesity Drug VK2735 to Enter Phase 3, NASH Therapy VK2809 Shows Promising Results, and Novel Treatments in Development Viking Therapeutics ...

How a Content Update Shook the Industry and Potentially Reshaped Vendor Relationships The recent IT outage caused by CRWD’s content ...

AFFINE Study Demonstrates Superiority of Giroctocogene Fitelparvovec Over Routine Prophylaxis Pfizer (PFE) recently announced encouraging results from the Phase 3 ...

Revenue Growth Driven by AI and AR Innovations in Beauty and Fashion SaaS Solutions Perfect Corp. (PERF), a global leader ...

Revenue Surpasses Expectations, but EPS Falls Short; New Vehicles on Track for 2025 Tesla (TSLA) reported mixed results for the ...

The biopharmaceutical sector has seen significant activity recently, with several companies making notable advancements that have caught the attention of ...

Spotify Technology (SPOT) surprised investors with robust fiscal second-quarter earnings Spotify Technology (SPOT) surprised investors with robust fiscal second-quarter earnings, ...

Successful Progression to Second Cohort in AD04 Pharmacokinetics Study Adial Pharmaceuticals (ADIL), a clinical-stage biopharmaceutical company dedicated to developing therapies ...

Navigating Price Sensitivity and Expanding into New Markets Coca-Cola has raised its annual organic sales and profit forecasts, signaling a ...